Moreover, isoquercetin, a glucoside derivative of quercetin, improved hepatic lipid accumulation through activating the AMPK pathway and inhibiting TGF-β signalling in a high-fat diet-induced nonalcoholic fatty liver disease rat model [42]. This evidence concerns the gene TGFB1 and metabolic dysfunction-associated steatotic liver disease.